BlackRock’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.8M Buy
4,294,151
+322,626
+8% +$1.11M ﹤0.01% 3144
2025
Q1
$8.46M Sell
3,971,525
-133,722
-3% -$285K ﹤0.01% 3360
2024
Q4
$13.1M Buy
4,105,247
+65,273
+2% +$208K ﹤0.01% 3240
2024
Q3
$53.9M Buy
4,039,974
+554,028
+16% +$7.4M ﹤0.01% 2395
2024
Q2
$34.8M Buy
3,485,946
+2,696,477
+342% +$26.9M ﹤0.01% 2600
2024
Q1
$9.39M Buy
789,469
+335,630
+74% +$3.99M ﹤0.01% 3326
2023
Q4
$1.82M Hold
453,839
﹤0.01% 4000
2023
Q3
$1.24M Sell
453,839
-79,939
-15% -$219K ﹤0.01% 4114
2023
Q2
$3.57M Buy
533,778
+33,345
+7% +$223K ﹤0.01% 3763
2023
Q1
$3.19M Buy
500,433
+254,676
+104% +$1.62M ﹤0.01% 3756
2022
Q4
$607K Buy
245,757
+1,423
+0.6% +$3.52K ﹤0.01% 4480
2022
Q3
$562K Sell
244,334
-201
-0.1% -$462 ﹤0.01% 4601
2022
Q2
$756K Buy
244,535
+613
+0.3% +$1.9K ﹤0.01% 4557
2022
Q1
$885K Buy
243,922
+95
+0% +$345 ﹤0.01% 4619
2021
Q4
$945K Sell
243,827
-2,453
-1% -$9.51K ﹤0.01% 4615
2021
Q3
$1.55M Sell
246,280
-28
-0% -$177 ﹤0.01% 4358
2021
Q2
$1.97M Sell
246,308
-57,748
-19% -$461K ﹤0.01% 4206
2021
Q1
$3.32M Buy
304,056
+188,490
+163% +$2.06M ﹤0.01% 4056
2020
Q4
$520K Buy
115,566
+178
+0.2% +$801 ﹤0.01% 4265
2020
Q3
$673K Buy
115,388
+2
+0% +$12 ﹤0.01% 4107
2020
Q2
$641K Sell
115,386
-217
-0.2% -$1.21K ﹤0.01% 4071
2020
Q1
$613K Buy
115,603
+9,201
+9% +$48.8K ﹤0.01% 3941
2019
Q4
$664K Buy
106,402
+17,919
+20% +$112K ﹤0.01% 4049
2019
Q3
$284K Buy
88,483
+289
+0.3% +$928 ﹤0.01% 4215
2019
Q2
$361K Buy
88,194
+394
+0.4% +$1.61K ﹤0.01% 4192
2019
Q1
$321K Buy
87,800
+326
+0.4% +$1.19K ﹤0.01% 4120
2018
Q4
$262K Buy
87,474
+403
+0.5% +$1.21K ﹤0.01% 4134
2018
Q3
$452K Buy
87,071
+110
+0.1% +$571 ﹤0.01% 4090
2018
Q2
$391K Buy
86,961
+250
+0.3% +$1.12K ﹤0.01% 4107
2018
Q1
$364K Sell
86,711
-1,165
-1% -$4.89K ﹤0.01% 4044
2017
Q4
$350K Buy
87,876
+165
+0.2% +$657 ﹤0.01% 4051
2017
Q3
$453K Buy
87,711
+280
+0.3% +$1.45K ﹤0.01% 4011
2017
Q2
$547K Sell
87,431
-8,006
-8% -$50.1K ﹤0.01% 3943
2017
Q1
$563K Buy
+95,437
New +$563K ﹤0.01% 3886